Polymyositis during pegylated α - Interferon ribavirin therapy for chronic hepatitis [7]

Indian Journal of Gastroenterology

Volumn 26, Issue 3, 2007, Pages 147-148

  John, Anil ^a,b   El Emadi, Samar ^a   Al Kaabi, Saad ^a   Morad, Nader ^a   Derbala, Moutaz ^a   Yakoub, Rafie ^a   Dweik, Nazeeh ^a   Butt, Mohammed Tariq ^a  

^a HAMAD MEDICAL CORPORATION   (Qatar)

^b NONE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CREATINE KINASE; PEGINTERFERON; PEGINTERFERON ALPHA2A; PREDNISOLONE; RIBAVIRIN; VIRUS ANTIBODY; VIRUS RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNITY; CASE REPORT; CHRONIC HEPATITIS; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; LETTER; LIMB WEAKNESS; LIVER BIOPSY; MUSCLE BIOPSY; MUSCLE STRENGTH; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMYOSITIS; QUADRICEPS FEMORIS MUSCLE; SCREENING; THYROID FUNCTION; VIREMIA;

FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MIDDLE AGED; POLYETHYLENE GLYCOLS; POLYMYOSITIS; RIBAVIRIN;

EID: 34548099253     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Duseiko G. Side effects of alpha interferon in chronic hepatitis C. Hepatology 1997;26(3 suppl 1):112S-121S.
2. Cirigliano G, Della Rossa A, Tavoni A, Viacava P, Bombardieri S. Polymyositis occurring during alpha interferon treatment for malignant melanoma - a case report. Rheumatol Intern 1999;19:65-7.
3. Dietrich LL, Bridges AJ, Albertini MR. Dermatomyositis after interferon alpha treatment. Med Oncol 2000;17:64-95.
4. Chung YH, Shong YK. Development of thyroid autoimmunity after administration of recombinant interferon for chronic hepatitis C. Am J Gastroenterol 1993;88;244-7.